• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Heartbeat Health, Withings Partner on New FDA Cleared ECG Smartwatch

by Fred Pennic 11/10/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Heartbeat Health, Withings Partner on New FDA Cleared ECG Smartwatch

What You Should Know:

– Heartbeat Health, a healthcare technology company working to deliver effective, efficient, and engaging heart care, announced that it has partnered with Withings, as they launch their ECG-enabled hybrid ScanWatch in the U.S. on November 9. 

– The Withings and Heartbeat integration is a game-changing development in the cardiovascular space – as Atrial Fibrillation, a form of irregular heart rhythm, is significantly underdiagnosed and, in some cases, can be an indicator of other underlying related cardiovascular issues.

FDA-Clearance

Withings, an early pioneer of the connected health revolution, known for bringing elegantly designed, health and wellness devices into the homes of consumers, recently received FDA clearance for its new hybrid smartwatch, ScanWatch – which has SpO2 (blood oxygenation) sensors and a built-in ECG (electrocardiogram) – capable of detecting Atrial Fibrillation. 

How It Works

To take an ECG, users simply rest their finger on the ScanWatch bezel and the measurement is completed within 30 seconds. Using the Withings Health Mate app combined with Heartbeat’s seamless technology integration, the ECG is then pinged real-time to Heartbeat Health’s virtual cardiology team for clinical interpretation. The result? Individuals can quickly become more informed and understand their heart health better — and share that information with their doctors.

“Withings’ approach to their ScanWatch is groundbreaking,” says Dr. Jeff Wessler, a cardiologist and Heartbeat Health’s co-founder and CEO. “We are thrilled to be the clinical partner to help Withings users understand their heart health better — quicker than has ever previously been possible.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: ecg, FDA, Smartwatch, Withings

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |